4TEEN4 Pharmaceuticals GmbH

About 4TEEN4 Pharmaceuticals GmbH

Trophic Communications is a strategic partner for life science companies, specializing in communications. They leverage a deep understanding of the science and business of drug development, as well as the capital needed for success, to present corporate stories and scientific concepts. Their client portfolio includes biotech start-ups, listed biopharmas, and small to large pharmaceutical companies.

Products & Services

Public Relations & Investor Relations:Strategic communication services tailored for life science companies to tell their unique stories.

U.S. Market Recognition:Services focused on enhancing visibility and recognition in the U.S. market for life science companies.

Media Coverage & Messaging:Crafting effective messaging and securing media coverage for clients.

Corporate Identity:Developing and maintaining a strong corporate identity for life science companies.

Specialties

Strategic Communications Public Relations Investor Relations Corporate Storytelling Scientific Concept Presentation

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series C T: - FT: Series C	A: 64000000 MR: - FA: €55 million FAN: 64000000	D: 2025-11-13 FD: 2025-11-13	4 investors

Series C Latest

2025-11-13

$64.0M

4 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

G

Gretchen Schweitzer

Managing Director

S

Stephanie May

Managing Director

F

Florence Roters

Managing Director

J

Jacob Verghese

Vice President

E

Eva Mulder

Vice President

V

Valeria Fisher

Account Director

View 13 more team members with Pro

Unlock Full Team Directory

Recent News